2022 Annual Meeting Virtual Experience | C25 - Telemedicine: Imagining the Unknown

Date Monday 04/25/22

Time 04:00 PM - 05:00 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Neil A. Busis, MD, FAAN

Moderator(s) Maciej M. Mrugala, MD, PhD, MPH, FAAN

Topic(s) Practice, Policy, and Ethics

Learning Objectives Participants should become familiar with the different modalities of telehealth, how to conduct a virtual examination, and methods of teaching learners at all stages about these methods of care. Expected future advances in telehealth will be presented.

CME Available 1.00 CME credit

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Systems-based Practice

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
04:00 PM - 04:40 PM EDT	Speaker	Telemedicine: Imagining the Unknown Neil A. Busis, MD, FAAN, Arielle M. Kurzweil, MD, FAAN
04:40 PM - 05:00 PM EDT	Q&A	Live Q&A Neil A. Busis, MD, FAAN, Arielle M. Kurzweil, MD, FAAN

Faculty Disclosures
Neil A. Busis, MD, FAAN	Dr. Busis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Academy of Neurology. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today.
Arielle M. Kurzweil, MD, FAAN	Dr. Kurzweil has nothing to disclose.
Maciej M. Mrugala, MD, PhD, MPH, FAAN	Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.